Effect of change of body mass index (BMI) during therapy on the efficacy of endocrine therapy in premenopausal patients with breast cancer: An analysis of the ABCSG-12 trial.
Georg Pfeiler(Medical University of Vienna), Michael Gnant(Austrian Breast & Colorectal Cancer Study Group), P Dubsky, Christian Marth(Nordic Society of Gynecologic Oncology), Christian Fesl(Austrian Breast & Colorectal Cancer Study Group), Richard Greil(Paracelsus Medical University), M. Seifert, Robert Königsberg(Kaiser-Franz-Josef-Spital), Brigitte Mlineritsch(Paracelsus Medical University), G. Steger(Aristotle University of Thessaloniki), Herbert Stöger(Medical University of Graz), H. Samonigg(Wilhelminen Hospital), R. Jakesz(Comprehensive Cancer Center Vienna), S. Poestlberger, CF Singer(Innsbruck Medical University), Vesna Bjelic‐Radisic(Helios Universitätsklinikum Wuppertal)
Cited by 4
Related Papers
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
Breast cancer
|The Lancet|2016|2.3k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k